Lin Cheng
Shanghai Medical College of Fudan University(CN)Jinan University(CN)Peking University(CN)Wenzhou Medical University(CN)Southern University of Science and Technology(CN)Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University(CN)Zhuzhou Central Hospital(CN)Changzhou No.2 People's Hospital(CN)Changzhou Third People's Hospital(CN)
Publications by Year
Research Areas
Immunotherapy and Immune Responses, Bone Tissue Engineering Materials, Immune cells in cancer, MicroRNA in disease regulation, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → Biocompatibility and osteogenesis of biomimetic nano-hydroxyapatite/polyamide composite scaffolds for bone tissue engineering(2007)749 cited
- → Anti-CD19 Chimeric Antigen Receptor T Cells in Combination With Nivolumab Are Safe and Effective Against Relapsed/Refractory B-Cell Non-hodgkin Lymphoma(2019)153 cited
- → RETRACTED ARTICLE: SARI inhibits angiogenesis and tumour growth of human colon cancer through directly targeting ceruloplasmin(2016)123 cited
- → Modulating the Tumor Microenvironment via Oncolytic Viruses and CSF-1R Inhibition Synergistically Enhances Anti-PD-1 Immunotherapy(2018)111 cited
- → SKLB1002, a Novel Potent Inhibitor of VEGF Receptor 2 Signaling, Inhibits Angiogenesis and Tumor Growth In Vivo(2011)101 cited
- → Anti-apoptotic and Anti-oxidative Roles of Quercetin After Traumatic Brain Injury(2014)